SCHF Among Ex-US Broad ETFs
End-of-day Nov 20, 2026 · 63 Ex-US broad ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.2% | −8.3% | −8.1% | −12.8% | +3.3% | +9.7% | +54.8% | +42.5% | +137.0% | +212.7% |
| Peer average | −3.2% | −8.1% | −7.8% | −11.9% | +0.8% | +6.1% | +49.6% | +35.8% | +119.0% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$25 of every $1,000 in SCHF is Samsung
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 005930.KSSamsung Electronics | Technology | 2.49% | $248.68 | 10.9M | $1.62B |
| 2 | ASML.ASAsml | Technology | 1.99% | $198.70 | 911K | $1.29B |
| 3 | 000660.KSSK Hynix | Technology | 1.86% | $185.89 | 1.4M | $1.21B |
| 4 | ROP.SWRoche PS PAR AG | Healthcare | 1.21% | $121.31 | 1.7M | $789.8M |
| 5 | HSBA.LHsbc | Financial Services | 1.05% | $105.06 | 40.6M | $684.0M |
| 6 | NOVN.SWNovartis AG | Healthcare | 1.03% | $102.66 | 4.4M | $668.4M |
| 7 | SHEL.LShell | Energy | 1.00% | $99.84 | 13.8M | $650.0M |
| 8 | RY.TORoyal Bank OF Canada | Financial Services | 0.96% | $96.03 | 3.3M | $625.2M |
| 9 | AZN.LAstrazeneca | Healthcare | 0.95% | $95.33 | 3.5M | $620.6M |
| 10 | NESN.SWNestle | Consumer Defensive | 0.94% | $94.02 | 6.1M | $612.1M |
| 11 | 7203.TToyota Motor | Consumer Cyclical | 0.81% | $80.73 | 24.8M | $525.6M |
| 12 | 8306.TMitsubishi UFJ Financial Group | Financial Services | 0.79% | $79.21 | 25.7M | $515.7M |
| 13 | SIE.DESiemens N AG | Industrials | 0.77% | $77.34 | 1.7M | $503.5M |
| 14 | SAP.DESAP | Technology | 0.73% | $72.96 | 2.3M | $475.0M |
| 15 | CBA.AXCommonwealth Bank OF Australia | Financial Services | 0.70% | $69.72 | 3.9M | $453.9M |
of the $655B in 176 Ex-US broad ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 005930.KS | Samsung Electronics | 2.49% |
| 2 | ASML.AS | Asml | 1.99% |
| 3 | 000660.KS | SK Hynix | 1.86% |
| 4 | ROP.SW | Roche PS PAR AG | 1.21% |
| 5 | HSBA.L | Hsbc | 1.05% |
| 6 | NOVN.SW | Novartis AG | 1.03% |
| 7 | SHEL.L | Shell | 1.00% |
| 8 | RY.TO | Royal Bank OF Canada | 0.96% |
| 9 | AZN.L | Astrazeneca | 0.95% |
| 10 | NESN.SW | Nestle | 0.94% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 24, 2026 | Jun 29, 2026 | $0.17 |
| Dec 11, 2025 | Dec 16, 2025 | $0.68 |
| Jun 25, 2025 | Jun 30, 2025 | $0.14 |
| Dec 13, 2024 | Dec 18, 2024 | $0.42 |
| Jun 26, 2024 | Jul 1, 2024 | $0.18 |
| Dec 6, 2023 | Dec 11, 2023 | $0.35 |
| Jun 21, 2023 | Jun 26, 2023 | $0.20 |
| Dec 7, 2022 | Dec 12, 2022 | $0.31 |
| Jun 22, 2022 | Jun 27, 2022 | $0.14 |
| Dec 30, 2021 | Jan 4, 2022 | $0.0234 |
| Dec 8, 2021 | Dec 13, 2021 | $0.43 |
| Jun 23, 2021 | Jun 28, 2021 | $0.17 |